[
    [
        {
            "time": "2023-10-10",
            "original_text": "贝达药业核心药累计销售额破80亿 新药有望成中国公司主导全球上市首款",
            "features": {
                "keywords": [
                    "贝达药业",
                    "核心药",
                    "累计销售额",
                    "80亿",
                    "新药",
                    "中国公司",
                    "全球上市",
                    "首款"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive",
                "financial_metric": "revenue_breakthrough",
                "innovation_potential": "high",
                "global_impact": "true"
            },
            "scores": {
                "News_content": "贝达药业核心药累计销售额破80亿 新药有望成中国公司主导全球上市首款",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]